Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 78

1.

Commencement of warfarin therapy in children following the Fontan procedure.

Crone E, Saliba N, George S, Hume E, Newall F, Jones S.

Thromb Res. 2013 Apr;131(4):304-7. doi: 10.1016/j.thromres.2013.01.018. Epub 2013 Feb 9.

PMID:
23399440
2.

A multicenter, randomized trial comparing heparin/warfarin and acetylsalicylic acid as primary thromboprophylaxis for 2 years after the Fontan procedure in children.

Monagle P, Cochrane A, Roberts R, Manlhiot C, Weintraub R, Szechtman B, Hughes M, Andrew M, McCrindle BW; Fontan Anticoagulation Study Group.

J Am Coll Cardiol. 2011 Aug 2;58(6):645-51. doi: 10.1016/j.jacc.2011.01.061.

3.

Safety of warfarin dosing in the intensive care unit following the Fontan procedure.

Thomas CA, Taylor K, Schamberger MS, Rotta AT.

Congenit Heart Dis. 2014 Jul-Aug;9(4):361-5.

PMID:
25247218
4.

Low dose oral anticoagulation therapy in Chinese children with congenital heart disease.

Cheung YF, Leung MP.

J Paediatr Child Health. 1998 Dec;34(6):563-7.

PMID:
9928651
5.

Factors associated with thrombotic complications after the Fontan procedure: a secondary analysis of a multicenter, randomized trial of primary thromboprophylaxis for 2 years after the Fontan procedure.

McCrindle BW, Manlhiot C, Cochrane A, Roberts R, Hughes M, Szechtman B, Weintraub R, Andrew M, Monagle P; Fontan Anticoagulation Study Group.

J Am Coll Cardiol. 2013 Jan 22;61(3):346-53. doi: 10.1016/j.jacc.2012.08.1023. Epub 2012 Dec 12.

6.

Analysis of warfarin therapy in pediatric patients: A prospective cohort study of 319 patients.

Streif W, Andrew M, Marzinotto V, Massicotte P, Chan AK, Julian JA, Mitchell L.

Blood. 1999 Nov 1;94(9):3007-14.

7.

Warfarin induced coagulopathy in children: assessment of a conservative approach.

Bauman ME, Black K, Bauman ML, Kuhle S, Bajzar L, Massicotte MP.

Arch Dis Child. 2011 Feb;96(2):164-7. doi: 10.1136/adc.2010.187104. Epub 2010 Nov 10.

PMID:
21068076
8.

Oral anticoagulation in a pediatric hospital: impact of a quality improvement initiative on warfarin management strategies.

Moffett BS, Parham AL, Caudilla CD, Mott AR, Gurwitch KD.

Qual Saf Health Care. 2006 Aug;15(4):240-3.

9.

Warfarin treatment outcomes in children monitored at home with a point-of-care device.

Biss T, Avery PJ, Walsh PM, Kamali F.

Thromb Haemost. 2011 Jun;105(6):1103-5. doi: 10.1160/TH10-09-0608. Epub 2011 Mar 24. No abstract available.

PMID:
21437355
10.

Two cases of warfarin-induced tracheobronchial calcification after Fontan surgery.

Eckersley L, Stirling J, Occleshaw C, Wilson N.

Pediatr Cardiol. 2014 Aug;35(6):954-8. doi: 10.1007/s00246-014-0880-z. Epub 2014 Mar 2.

PMID:
24584210
11.

Safety and efficacy of warfarin in paediatric patients with prosthetic cardiac valves: a retrospective audit.

Wong CS, Batchelor K, Bua J, Newall F.

Thromb Res. 2011 Oct;128(4):331-4. doi: 10.1016/j.thromres.2011.04.020. Epub 2011 May 26.

PMID:
21620442
12.

The efficacy of 3-mg warfarin initiating dose in adult Thai patients, who required long-term anticoagulant therapy.

Suwanawiboon B, Kongtim P, Chinthammitr Y, Ruchutrakool T, Wanachiwanawin W.

J Med Assoc Thai. 2011 Feb;94 Suppl 1:S225-31.

PMID:
21721451
13.

Warfarin therapy in children who require long-term total parenteral nutrition.

Newall F, Barnes C, Savoia H, Campbell J, Monagle P.

Pediatrics. 2003 Nov;112(5):e386.

PMID:
14595081
14.

Prevalence and predictors of haemostatic complications in 412 Fontan patients: their relation to anticoagulation and haemodynamics.

Ohuchi H, Yasuda K, Miyazaki A, Ono S, Hayama Y, Negishi J, Noritake K, Mizuno M, Yamada O.

Eur J Cardiothorac Surg. 2015 Mar;47(3):511-9. doi: 10.1093/ejcts/ezu145. Epub 2014 Apr 3.

PMID:
24699205
15.

Management of warfarin in children with heart disease.

Mahle WT, Simpson SA, Fye P, McConnell ME.

Pediatr Cardiol. 2011 Dec;32(8):1115-9. doi: 10.1007/s00246-011-9984-x. Epub 2011 Apr 17.

PMID:
21499856
16.

Warfarin anticoagulation after congenital heart surgery at a large children's hospital.

Lowry AW, Moffett BS, Moodie D, Knudson JD.

Pediatr Cardiol. 2012 Dec;33(8):1377-82. doi: 10.1007/s00246-012-0351-3. Epub 2012 May 16.

PMID:
22588460
18.

Readmissions for warfarin-related bleeding in pediatric patients after hospital discharge.

Moffett BS, Kim S, Bomgaars LR.

Pediatr Blood Cancer. 2013 Sep;60(9):1503-6. doi: 10.1002/pbc.24546. Epub 2013 Apr 20.

PMID:
23606286
19.

Long-term anticoagulation therapy and thromboembolic complications after the Fontan procedure.

Cheung YF, Chay GW, Chiu CS, Cheng LC.

Int J Cardiol. 2005 Jul 20;102(3):509-13.

PMID:
16004898
20.

Pharmacy-managed anticoagulation: assessment of in-hospital efficacy and evaluation of financial impact and community acceptance.

Donovan JL, Drake JA, Whittaker P, Tran MT.

J Thromb Thrombolysis. 2006 Aug;22(1):23-30. Review.

PMID:
16786229

Supplemental Content

Support Center